Literature DB >> 17703529

Yearly zoledronic acid in postmenopausal osteoporosis.

Roger Karam, John Camm, Michael McClung.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17703529

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  31 in total

1.  A population-based 2-year follow-up study on the relationship between bisphosphonates and the risk of stroke.

Authors:  J-H Kang; J J Keller; H-C Lin
Journal:  Osteoporos Int       Date:  2012-01-20       Impact factor: 4.507

2.  Bisphosphonates and risk of atrial fibrillation: a meta-analysis.

Authors:  Seo Young Kim; Min Jung Kim; Suzanne M Cadarette; Daniel H Solomon
Journal:  Arthritis Res Ther       Date:  2010-02-19       Impact factor: 5.156

3.  Oral bisphosphonates and atrial fibrillation.

Authors:  Sumit R Majumdar
Journal:  BMJ       Date:  2008-03-11

Review 4.  Adverse effects of bisphosphonates: implications for osteoporosis management.

Authors:  Kurt A Kennel; Matthew T Drake
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

5.  Use of oral bisphosphonates and risk of venous thromboembolism: a population-based case-control study.

Authors:  A L Lamberg; E Horvath-Puho; S Christensen; H T Sørensen
Journal:  Osteoporos Int       Date:  2009-12-09       Impact factor: 4.507

6.  Efficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis.

Authors:  Ege Can Serefoglu; Zafer Tandogdu
Journal:  Ther Clin Risk Manag       Date:  2010-05-25       Impact factor: 2.423

Review 7.  Prevention of osteoporosis-related fractures among postmenopausal women and older men.

Authors:  Poupak Rahmani; Suzanne Morin
Journal:  CMAJ       Date:  2009-10-19       Impact factor: 8.262

8.  Use of bisphosphonates among women and risk of atrial fibrillation and flutter: population based case-control study.

Authors:  Henrik Toft Sørensen; Steffen Christensen; Frank Mehnert; Lars Pedersen; Roland D Chapurlat; Steven R Cummings; John A Baron
Journal:  BMJ       Date:  2008-03-11

9.  Bisphosphonates and atrial fibrillation: Bayesian meta-analyses of randomized controlled trials and observational studies.

Authors:  Anselm Mak; Mike W L Cheung; Roger Chun-Man Ho; Alicia Ai-Cia Cheak; Chak Sing Lau
Journal:  BMC Musculoskelet Disord       Date:  2009-09-21       Impact factor: 2.362

10.  Treatment of osteoporosis with annual iv zoledronic acid: effects on hip fracture.

Authors:  Roland D Chapurlat
Journal:  Ther Clin Risk Manag       Date:  2009-05-04       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.